SARS-CoV-2 Spike Antikörper (B.1.351 – beta)
Kurzübersicht für SARS-CoV-2 Spike Antikörper (B.1.351 – beta) (ABIN7540496)
Target
Alle SARS-CoV-2 Spike Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- B.1.351 – beta
-
Hersteller Produkt- Nr.
- 200-301-mu5
-
Hersteller
- Rockland
-
Verwendungszweck
- SARS-CoV-2 Beta Variant Spike Protein Antibody
-
Kreuzreaktivität (Details)
- SARS-CoV-2 Beta Variant Spike Protein Antibody is directed against SARS Coronavirus 2 Spike (S2) Beta B.1.
-
Sterilität
- Sterile filtered
-
Immunogen
- This protein A purified antibody was produced by repeated immunizations in mice with a synthetic peptide from an internal region of the SARS-CoV-2 Spike protein.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
ELISA_Dilution: User Optimized
Western_Blot_Dilution: User Optimized
-
Kommentare
-
Anti-SARS-CoV-2 Beta Variant Spike Protein Antibody has been tested for use in ELISA and shows reactivity to SARS Coronavirus 2 Spike (S2) Beta Variant Protein. Specific conditions for reactivity should be optimized by the end user.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: None
Preservative: 0.01 % (w/v) Sodium Azide -
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
-
Haltbarkeit
- 12 months
-
-
- SARS-CoV-2 Spike
-
Andere Bezeichnung
- SARS-CoV-2 Spike Protein
-
Hintergrund
- Mouse anti-SARS CoV 2 Spike Protein (Beta Variant) Antibody, Spike glycoprotein antibody, SARS CoV2 antibody, 2019-nCoV, COVID-19, S glycoprotein, Severe acute respiratory syndrome antibody, Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2),SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) the virus that causes the disease COVID-19, is related to SARS-CoV, MERS-CoV, and other betacoronaviruses (HKU1, NL63, OC43 and 229E). SARS-CoV-2 is an enveloped positive strand RNA virus that consists of several structural proteins including spike (S) protein, envelope (E) protein, membrane (M) protein and nucleocapsid (N) protein, and other non-structural proteins (NSPs). Spike proteins located on the surface of the virus, have a high affinity for binding to human receptor ACE2 (angiotensin-converting enzyme 2) within respiratory epithelial which serves as an entry mechanism for infection. As such, the S protein may be vital to blocking viral infection and vaccine development. Anti-SARS-CoV-2 Beta Variant Spike Protein Antibody is useful for researchers interested in diagnostics, vaccines, and viral research.
-
UniProt
- P0DTC2
Target
-